Recite me link

I write under the Freedom of Information Act to request copies of all Clinical policies and procedures, guidelines and standards that were in use to govern the clinical decisions concerning the treatment of Haemolytic disease of the newborn (HDN) also known as Rhesus Disease/Maternal Antibodies made in the Neo-natal units within the Maidstone & Tunbridge Wells NHS Trust from 1998 to 2002.

These documents will include but not be limited to the management of :

Rhesus Disease
Haemolytic Disease of the newborn (HDN)
Neo natal jaundice in pre-term and term neonates
Hyperbilirubinemia in the newborn
Phototherapy
Exchange transfusions in neonates

And any other interventions/guidelines into how to treat Haemolytic Jaundice in newborns.

These documents pre-date NICE guidelines and the parameters of 1998 – 2002 are especially important.

Download response Haemolytic disease of the newborn (HDN) also known as Rhesus Disease-Maternal Antibodies. 300920